ААР — Американская академия педиатрии (American Academy of Pediatrics)
ABC — алгоритм неотложной помощи «дыхательные пути-дыхание-кровообращение» (Airways-Breathing-Circulation)
АВСА3 — белковый член АТФ-связывающей кассеты АЗ
АВСВ11 — ген АТФ-связывающей кассеты, 11-й член подсемейства В (ATP-binding cassette, subfamily В member 11)
АВСВ4 — ген АТФ-связывающей кассеты, 4-й член подсемейства В (ATP-binding cassette 4 gene)
АВСС2 — ген, кодирующий 2-й член подсемейства С ABCDE — алгоритм неотложной помощи «дыхательные пути-дыхание-кровообращение-неврологический статус-внешний вид» (Airways-Breathing-Circulation-Disability-Exposure)
ABCG5/G8 — гетеродимер переносчика АТФ-связывающей кассеты ABCG5 и ABCG8 (Th eheterodimer of ATP-binding cassette transporter ABCG5 and ABCG8)
AC — до еды (при назначениях) — ante cibum
АСЕР — Американская коллегия врачей неотложной помощи (American College of Emergency Physicians)
ACOG — Американская коллегия акушеров и гинекологов (American College of Obstetricians and Gynecologists)
AHA — Американская кардиологическая ассоциация (American Heart Association)
AIS — аденокарцинома in situ (adenocarcinoma in situ)
ALTE — очевидное опасное для жизни событие (apparent life-threatening event)
APLS — курсы расширенных реанимационных мероприятий в педиатрии, спонсируемые Американской академией педиатрии и Американской коллегией врачей неотложной помощи (Advanced Pediatric Life Support)
AUC — площадь под фармакокинетической кривой (area under the curve)
AVPU — шкала для оценки уровня сознания («в ясном сознании»; «реакция на вербальные раздражители»; «реакция на боль»; «без сознания») (alert, verbal, pain, unresponsive)
ABCC2 - АТФ-связывающих кассет (ATP-binding cassette sub-family C member 2)
mTOR — мишень рапамицина в клетках млекопитающих (mammalian target ofrapamycin)
NB! — важно, обратить внимание (Nota bene)
NCI — Национальный институт рака (National Cancer Institute)
NICE — Национальный институт здоровья и клинического совершенствования (качества медицинской помощи) Великобритании (National Institute for Health and Clinical Excellence)
NK — естественные клетки-киллеры (natural killer)
NMDA — N-метил-D-аспартат (N-methyl-D-aspartate)
NMDA — N-метил-D-аспартатные рецепторы
NNT — число больных, которых необходимо пролечить, чтобы достичь какого-то указанного эффекта (Number Need to Treatment)
OR — отношение шансов (odds ratio)
paCO2 — парциальное давление углекислого газа в артериальной крови
PALS — курсы расширенных реанимационных мероприятий в педиатрии (Pediatric Advanced Life Support)
PANDAS — аутоиммунное нейропсихиатрическое расстройство в детском возрасте, ассоциированное со стрептококковой инфекцией (Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection)
PANS — острый нейропсихиатрический синдром в детском возрасте (Pediatric acute-onset neuropsychiatric syndrome)
paO2 — парциальное давление кислорода в артериальной крови
PAS — фуксинсернистая кислота, реактив Шиффа (periodic acid-Shiff)
PC — после еды (при назначениях) — post cibum рСO2 — парциальное давление углекислого газа PCSK-9 — пропротеиновая конвертаза субтилизин-кексинового типа 9 (proprotein convertase subtilisin/kexin type 9)
PD — плотность мощности (power density)
PD-1 — программируемая клеточная смерть 1 (англ. programmed cell death 1)
PFAPA — периодическая лихорадка с афтозным стоматитом, фарингитом и лимфаденитом (Periodic Fevers with Aphthous stomatitis, Pharyngitis and Adenitis)
PIM — показатель летального исхода у детей (Pediatric Index of Mortality)
piO2 — парциальное давление кислорода
во вдыхаемом воздухе
рО2 — парциальное давление кислорода
POLG — субъединица ДНК-полимеразы у
POP — пролапс тазовых органов (pelvic organ prolapse) POP-Q — количественная оценка пролапса тазовых органов (Pelvic Organ Prolapse Quantification)
PRISA II — оценка риска госпитализации у детей II (Pediatric Risk of Admission)
PRISM — риск летального исхода у детей (Pediatric Risk of Mortality)
PRN — при (по) необходимости (Pro re nata — при возникновении обстоятельств)
PRSS — ген сериновой протеазы
PS. — примечание (Post scriptum)
PUVA-терапия — псорален-ультрафиолет А-терапия (psoralen and ultraviolet А)
Q#H — каждые # часов (при назначениях) — quaque... hora
QAM — каждое утро (при назначениях) — quaque ante meridiem
QPM — каждый вечер (при назначениях) — quaque post meridiem
RAG — ген, активирующий рекомбиназу
REMS — Программа по оценке и снижению риска (Risk Evaluation and Mitigation Strategy)
RePEAT — пересмотренный инструмент для оценки педиатрической неотложной медицинской помощи (Revised Pediatric Emergency Assessment Tool)
RF — ревматоидный фактор
Rh — резус(-фактор)
Rh«+» — резус-положительный
Rh«-» — резус-отрицательный
ROCA — Алгоритм риска развития рака яичников (Risk of Ovarian Cancer Algorithm)
ROHHAD — быстро развивающееся ожирение с дисфункцией гипоталамуса, гиповентиляцией и спонтанной дисрегуляцией (rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation)
ROMA — Алгоритм риска наличия злокачественной опухоли яичника (Risk of Ovarian Malignancy Algorithm)
RR — относительный риск (relative risk или risk ratio)
RW — реакция Вассермана (reaction of Wassermann)
SaO2 — сатурация артериальной крови кислородом
SatO2 — насыщение крови кислородом
SCJ — зона перехода плоского эпителия в цилиндрический (Scuamocolumnar Junction)
ScvO2 — насыщение кислородом центральной венозной крови (central venous oxygen saturation)
SD — стандартное отклонение (standart deviation) SEER — эпидемиология эпиднадзора и данных о конечных результатах (Surveillance Epidemiology and End Result)
SFTPA — ген сурфактантного белка A
SFTPB — ген сурфактантного белка В
SFTPC — ген сурфактантного белка С
SILS — хирургия единого лапароскопического доступа (single-incision laparoscopic surgery)
В ходе подготовки статей по СПКЯ и гиперандрогении в гинекологии для пользователей сайта МедУнивер использованы труды следующих авторов:
Amer SA, Gopalan V, Li TC, et al: Long term follow-up of patients with polycystic ovarian syndrome after laparoscopic ovarian drilling: clinical outcome. Hum Reprod 17:2035, 2002
American College of Obstetricians and Gynecologists: Diagnosis of abnormal uterine bleeding in reproductive-aged women. Practice Bulletin No. 128, July 2012, Reaffirmed 2016
American College of Obstetricians and Gynecologists: Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Committee Opinion No. 651, December 2015, Reaffirmed 2017
American College of Obstetricians and Gynecologists: Polycystic ovarian syndrome. Practice Bulletin No. 194, June 2018
American Diabetes Association: 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes Care 42(1 suppl):S13, 2019
American Society for Reproductive Medicine: Current evaluation of amenorrhea. Fertil Steril 90(5 Suppl):S219, 2008
American Society for Reproductive Medicine: Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline. Fertil Steril 108(3):426, 2017
Arroyo A, Laughlin GA, Morales AJ, et al: Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab 82:3728, 1997
Azziz R: The evaluation and management of hirsutism. Obstet Gynecol 101:995, 2003
Azziz R, Carmina E, Dewailly D, et al: Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91:4237, 2006
Bahri Khomami M, Joham AE, Boyle JA, et al: Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity—a systematic review, meta-analysis, and meta-regression. Obes Rev 20(5):659, 2019
Banaszewska B, Duleba A, Spaczynski R: Lipids in polycystic ovary syndrome: role of hyperinsulinemia and effects of metformin. Am J Obstet Gynecol 194:1266, 2006
Barbieri RL, Ryan KJ: Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol 147(1):90, 1983
Barry JA, Azizia MM, Hardiman PJ: Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 20(5):748, 2014
Benham JL, Yamamoto JM, Friedenreich CM, et al: Role of exercise training in polycystic ovary syndrome: a systematic review and meta-analysis. Clin Obes 8(4):275, 2018
Bergh C, Carlsson B, Olsson JH, et al: Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril 59:323, 1993
Betti R, Bencini PL, Lodi A, et al: Incidence of polycystic ovaries in patients with late onset or persistent acne: hormonal reports. Dermatologica 181:109, 1990
Brown J, Farquhar C, Lee O, et al: Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev 2:CD000194, 2009
Bunker CB, Newton JA, Kilborn J, et al: Most women with acne have polycystic ovaries. Br J Dermatol 121:675, 1989
Burgers JA, Fong SL, Louwers YV, et al: Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what’s the difference? J Clin Endocrinol Metab 95(12):E485, 2010
Cannarella R, Condorelli RA, Mongio? LM, et al: Does a male polycystic ovarian syndrome equivalent exist? J Endocrinol Invest 41(1):49, 2018
Carmina E, Oberfield SE, Lobo RA: The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol 203(3):201.e1, 2010
Chen W, Thiboutot D, Zouboulis CC: Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol 119:992, 2002
Clayton R, Ogden V, Hodgkinson J, et al: How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol 37:127, 1992
Cook H, Brennan K, Azziz R: Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism? Fertil Steril 96(5):1266, 2011
Crapo L: Cushing’s syndrome: a review of diagnostic tests. Metab Clin Exp 28:955, 1979
Cruz PD Jr, Hud JA Jr: Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans. J Invest Dermatol 98(6 suppl):82S, 1992
Cui Y, Shi Y, Cui L, et al: Age-specific serum antim?llerian hormone levels in women with and without polycystic ovary syndrome. Fertil Steril 102(1):230, 2014
Dahlgren E, Janson PO, Johansson S, et al: Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 71:599, 1992
Day F, Karaderi T, Jones MR, et al: Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet 14(12):e1007813, 2018
Deeks AA, Gibson-Helm ME, Paul E, et al: Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum Reprod 26(6):1399, 2011
Derksen J, Nagesser SK, Meinders AE, et al: Identification of virilizing adrenal tumors in hirsute women. N Engl J Med 331:968, 1994
Dewailly D, Andersen CY, Balen A, et al: The physiology and clinical utility of anti-mullerian hormone in women. Hum Reprod Update 20(3):370, 2014a
Dewailly D, Gronier H, Poncelet E, et al: Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod 26(11):3123, 2011
Dewailly D, Lujan ME, Carmina E, et al: Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 20(3):334, 2014b
Ding EL, Song Y, Manson JE, et al: Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 361(12):1152, 2009
Dokras A, Bochner M, Hollinrake E: Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 106:131, 2005
Dokras A, Clifton S, Futterweit W, et al: Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 97(1):225, 2012
Dokras A, Clifton S, Futterweit W, et al: Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol 117(1):145, 2011
Dokras A, Stener-Victorin E, Yildiz BO, et al: Androgen Excess—Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril 109(5):888, 2018
Dramusic V, Rajan U, Wong YC, et al: Adolescent polycystic ovary syndrome. Ann NY Acad Sci 816:194, 1997
Dumesic DA, Goodarzi MO, Chazenbalk GD, Abbott DH: Intrauterine environment and polycystic ovary syndrome. Semin Reprod Med 32:159, 2014
Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanisms and implication for pathogenesis. Endocr Rev 18:774, 1997
Dunaif A, Finegood DT: Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:942, 1996
Dunaif A, Segal KR, Futterweit W, et al: Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38: 1165, 1989
Dunaif A, Segal KR, Shelley DR, et al: Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41:1257, 1992
Elting MW, Korsen TJ, Rekers-Mombarg LT: Women with polycystic ovary syndrome gain regular menstrual cycles when aging. Hum Reprod 15, 24, 2000
Escobar-Morreale HF, Carmina E, Dewailly D, et al: Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 18(2):146, 2012
Farquhar C, Brown J, Marjoribanks J: Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 6:CD001122, 2012
Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440, 1961
Flannery CA, Rackow B, Cong X, et al: Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI. Pediatr Diabetes 14(1):42, 2013
Fogel RB, Malhotra A, Pillar G, et al: Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 86:1175, 2001
Fruzzetti F, de Lorenzo D, Parrini D, et al: Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women. J Clin Endocrinol Metab 79(3):831, 1994
Gold LS: The MORE trial: effectiveness of adapalene gel 0.1% in real-world dermatology practices. Cutis 78(1 Suppl):12, 2006
Goodman NF, Cobin RH, Futterweit W, et al: American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome — part 2. Endocr Pract 21(12):1415, 2015
Gopal M, Duntley S, Uhles M, et al: The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep Med 3(5):401, 2002
Gottschau M, Kjaer SK, Jensen A, et al: Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study. Gynecol Oncol 136(1):99, 2015
Gupta M, Mysore V: Classifications of patterned hair loss: a review. J Cutan Aesthet Surg 9(1):3, 2016
Haqq L, McFarlane J, Dieberg G, et al: The effect of lifestyle intervention on body composition, glycemic control, and cardiorespiratory fitness in polycystic ovarian syndrome: a systematic review and meta-analysis. Int J Sport Nutr Exerc Metab 25(6):533, 2015
Han Y, Li Y, He B: GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis. Reprod Biomed Online 39(2):332, 2019
Haoula Z, Salman M, Atiomo W: Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod 27(5):1327, 2012
Harrison CL, Lombard CB, Moran LJ, et al: Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update 17(2):171, 2011
Hatch R, Rosenfield RL, Kim MH, et al: Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140:815, 1981
Hayes FJ, Taylor AE, Martin KA, et al: Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics. J Clin Endocrinol Metab 83:2243, 1998
Hickey M, Doherty DA, Atkinson H, et al: Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Hum Reprod 26(6):1469, 2011
Homburg R, Armar NA, Eshel A, et al: Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 297(6655):1024, 1998
Homburg R, Ray A, Bhide P, et al: The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study. Hum Reprod 28(4):1077, 2013
Huber-Buchholz MM, Carey DG, Norman RJ: Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 84:1470, 1999
Hughesdon PE: Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called “hyperthecosis.” Obstet Gynecol Surv 37:59, 1982
Iliodromiti S, Kelsey TW, Anderson RA, et al: Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab 98(8):3332, 2013
Jaatinen TA, Anttila L, Erkkola R, et al: Hormonal responses to physical exercise in patients with polycystic ovarian syndrome. Fertil Steril 60:262, 1993
Javed Z, Papageorgiou M, Deshmukh H, et al: Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: a randomized controlled study. Clin Endocrinol (Oxf) 90(6):805, 2019
Jick SS, Terris BZ, Jick H: First trimester topical tretinoin and congenital disorders. Lancet 341:1181, 1993
Joham AE, Boyle JA, Ranasinha S, et al: Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women’s Health. Hum Reprod 29(4):802, 2014a
Joham AE, Ranasinha S, Zoungas S, et al: Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome. J Clin Endocrinol Metab 99(3):E447, 2014b
Kahal H, Kyrou I, Uthman OA, et al: The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep Breath May 20, 2019 [Epub ahead of print]
Kahsar-Miller MD, Nixon C, Boots LR, et al: Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 75:53, 2001
Kazemi M, Pierson RA, Lujan ME, et al: Comprehensive evaluation of type 2 diabetes and cardiovascular disease risk profiles in reproductive-age women with polycystic ovary syndrome: a large Canadian cohort. J Obstet Gynaecol Can 41(10):1453, 2019
Kiddy DS, Hamilton-Fairley D, Bush A, et al: Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 36:105, 1992
Kiszka AN, Wilburn-Wren KR: Clitoromegaly (update) in Hoffman BL, Schorge JO, Bradshaw KD, et al (eds): Williams Gynecology, 3rd edition Online. Available at: https://accessmedicina.mhmedical.com/content.aspx?bookid=2162§ionid=165577484. New York, McGraw-Hill, 2019
Kite C, Lahart IM, Afzal I, et al: Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis. Syst Rev 8(1):51, 2019
Kristensen SL, Ramlau-Hansen CH, Ernst E, et al: A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed. Hum Reprod 25(12):3117, 2010
Lee I, Cooney LG, Saini S, et al: Increased risk of disordered eating in polycystic ovary syndrome. Fertil Steril 107(3):796, 2017
Legro RS: Is there a male phenotype in polycystic ovary syndrome families? J Pediatr Endocrinol Metab 13(5 suppl):1307, 2000
Legro RS, Gnatuk CL, Kunselman AR, et al: Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 90:3236, 2005
Legro RS, Kunselman AR, Demers L, et al: Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. J Clin Endocrinol Metab 87:2134, 2002
Legro RS, Kunselman AR, Dodson WC, et al: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165, 1999
Legro RS, Kunselman AR, Dunaif A: Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 111:607, 2001
Levy LL, Emer JJ: Female pattern alopecia: current perspectives. Int J Womens Health 5:541, 2013
Leyden J, Thiboutot DM, Shalita AR, et al: Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. Arch Dermatol 142:605, 2006
Li R, Zhang Q, Yang D, et al: Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod 28(9):2562, 2013
Lim SS, Norman RJ, Davies MJ, et al: The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev 14(2):95, 2013
Liu DM, Torchen LC, Sung Y, et al: Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome. Hum Reprod 29(12):2764, 2014
Lizneva D, Suturina L, Walker W, et al: Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106(1):6, 2016
Lo JC, Feigenbaum SL, Yang J, et al: Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab 91(4):1357, 2006
Loureiro KD, Kao KK, Jones KL, et al: Minor malformations characteristics of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet A 136:117, 2005
Lujan ME, Jarrett BY, Brooks ED, et al: Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume. Hum Reprod 28(5):1361, 2013
Moghetti P, Castello R, Magnani CM, et al: Clinical and hormonal effects of the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism. J Clin Endocrinol Metab 79:1115, 1994
Moghetti P, Tosi F, Tosti A, et al: Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial. J Clin Endocrinol Metab 85:89, 2000
Moore RL, Devere TS: Epidermal manifestations of internal malignancy. Dermatol Clin 26(1):17, 2008
Moran C, Knochenhauer E, Boots LR, et al: Adrenal androgen excess in hyperandrogenism: relation to age and body mass. Fertil Steril 71:671, 1999
Moran C, Tapia MC, Hernandez E, et al: Etiological review of hirsutism in 250 patients. Arch Med Res 25:311, 1994
Mykhalchenko K, Lizneva D, Trofimova T, et al: Genetics of polycystic ovary syndrome. Expert Rev Mol Diagn 17(7):723, 2017
Nagamani M, Dinh TV, Kelver ME: Hyperinsulinemia in hyperthecosis of the ovaries. Am J Obstet Gynecol 154:384, 1986
Nagamani M, Osuampke C, Kelver ME: Increased bioactive luteinizing hormone levels and bio/immuno ratio in women with hyperthecosis of the ovaries: possible role of hyperinsulinemia. J Clin Endocrinol Metab 84(5):1685, 1999
National Cancer Institute: Surveillance, Epidemiology, and End Results Program: cancer of the corpus and uterus, NOS (invasive). SEER incidence and U.S. death rates, age-adjusted and age-specific rates, by race. 2019. Available at: https://seer.cancer.gov/archive/csr/1975_2016/browse_csr.php?sectionSEL=7%26pageSEL=sect_07_table.05 Accessed June 23, 2019
National Institutes of Health: Evidence-based methodology workshop on polycystic ovary syndrome. December 3–5, 2012. Executive summary. Final report. Available at: https://prevention.nih.gov/sites/default/files/2018-06/FinalReport.pdf Accessed June 24, 2019
Naver KV, Grinsted J, Larsen SO, et al: Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia. BJOG 121(5):575, 2014
Nestler JE, Jakubowicz DJ, Evans WS, et al: Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338:1876, 1998
Nieman LK, Biller BM, Findling JW, et al: The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):1526, 2008
O’Driscoll JB, Mamtora H, Higginson J, et al: A prospective study of the prevalence of clearcut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol 41:231, 1994
Palmert MR, Gordon CM, Kartashov AI, et al: Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 87(3):1017, 2002
Palomba S, de Wilde MA, Falbo A, et al: Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update 21(5):575, 2015
Palomba S, Falbo A, Orio F Jr, et al: Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 92(5):1646, 2009
Panidis D, Skiadopoulos S, Rousso D, et al: Association of acanthosis nigricans with insulin resistance in patients with polycystic ovary syndrome. Br J Dermatol 132:936, 1995
Pasquali R, Antenucci D, Casimirri F, et al: Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 68:173, 1989
Patel NU, Roach C, Alinia H, et al: Current treatment options for acanthosis nigricans. Clin Cosmet Investig Dermatol 11:407, 2018
Peppard PE, Young T, Palta M, et al: Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 284(23):3015, 2000
Pigny P, Jonard S, Robert Y, et al: Serum anti-M?llerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 91(3):941, 2006
Polson DW, Adams J, Wadsworth J, et al: Polycystic ovaries—a common finding in normal women. Lancet 1:870, 1988
Quinn M, Shinkai K, Pasch L, et al: Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features. Fertil Steril 101(4):1129, 2014
Rebar R, Judd HL, Yen SS, et al: Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 57:1320, 1976
Rebuffe-Scrive M, Cullberg G, Lundberg PA, et al: Anthropometric variables and metabolism in polycystic ovarian disease. Horm Metab Res 21:391, 1989
Regan L, Owen EJ, Jacobs HS: Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 336:1141, 1990
Reyes-Mu?oz E, Ortega-Gonz?lez C, Mart?nez-Cruz N, et al: Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical-biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study. BMJ Open 6(7):e012107, 2016
Sagle M, Bishop K, Ridley N, et al: Recurrent early miscarriage and polycystic ovaries. BMJ 297:1027, 1988
Schneider JG, Tompkins C, Blumenthal RS, et al: The metabolic syndrome in women. Cardiol Rev 14:286, 2006
Senaratna CV, Perret JL, Lodge CJ, et al: Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev 34:70, 2017
Sobbrio GA, Granata A, D’Arrigo F, et al: Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation. Acta Eur Fertil 21:139, 1990
Tagatz GE, Kopher RA, Nagel TC, et al: The clitoral index: a bioassay of androgenic stimulation. Obstet Gynecol 54(5):562, 1979
Talbott E, Clerici A, Berga SL, et al: Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-controlled study. J Clin Epidemiol 51:415, 1998
Talbott E, Guzick D, Clerici A, et al: Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15:821, 1995
Tasali E, Van Cauter E, Hoffman L, et al: Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome. J Clin Endocrinol Metab 93(10):3878, 2008
Taylor AE, McCourt B, Martin KA, et al: Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2248, 1997
Teede H, Misso M, Tassone EC, et al: Anti-M?llerian hormone in PCOS: a review informing international guidelines. Trends Endocrinol Metab 30(7):467, 2019
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41, 2004
Torchen LC, Kumar A, Kalra B, et al: Increased antim?llerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome. Fertil Steril 106(1):50, 2016
van Santbrink EJ, Hop WC, Fauser BC: Classification of normogonadotropin infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of PCOS. Fertil Steril 67:452, 1997
Vanky E, Stridsklev S, Heimstad R, et al: Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 95(12):E448, 2010
Veltman-Verhulst SM, van Haeften TW, Eijkemans MJ, et al: Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome. Hum Reprod (12):3123, 2010
Venturoli S, Marescalchi O, Colombo FM, et al: A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism. J Clin Endocrinol Metab 84:1304, 1999
Verkauf BS, Von Thron J, O’Brien WF: Clitoral size in normal women. Obstet Gynecol 80(1):41, 1992
Vgontzas AN, Legro RS, Bixler EO, et al: Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiless: role of insulin resistance. J Clin Endocrinol Metab 86:517, 2001
Vigorito C, Giallauria F, Palomba S, et al: Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 92(4):1379, 2007
Vink JM, Sadrzadeh S, Lambalk CB, et al: Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 91(6): 2100, 2006
Waldstreicher J, Santoro NF, Hall HJE, et al: Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence of partial gonadotroph desensitization. J Clin Endocrinol Metab 66:165, 1988
Wild RA, Rizzo M, Clifton S, et al: Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 95(3):1073, 2011
Witchel SF, Oberfield S, Rosenfield RL, et al: The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr 83:376, 2015
Wolf JE Jr, Shander D, Huber F, et al: Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair. Int J Dermatol 46(1):94, 2007
Yildiz BO, Yarali H, Oguz H, et al: Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2031, 2003
Zaenglein AL, Pathy AL, Schlosser BJ, et al: Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 74(5):945, 2016
Zawadzki JK, Dunaif A: Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Dunaif A, Givens JR, Haseltine F, et al (eds): Polycystic Ovary Syndrome. Boston, Blackwell Scientific, 1990, p 377
Zhao H, Lv Y, Li L, et al: Genetic studies on polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 37:56, 2016
Труды отечественных авторов при подготовке статей по гинекологии для пользователей сайта - не использовались, так как их вы всегда можете найти в библиотеках.
